AJMC - The American Journal of Managed Care’s Post

Marius Hoeper, MD, discusses the recently FDA-approved pulmonary arterial hypertension (PAH) treatment sotatercept, discussing its mechanism of action, possible cost implications, and potential advantages and disadvantages compared with existing foundational therapies. Learn more about sotatercept with this episode: https://bit.ly/3X7qDqZ #ManagedCare #PulmonaryHypertension

Today, U.S. News & World Report published its 2024-2025 Best Hospitals rankings, marking the 35th anniversary of this comprehensive evaluation of nearly 5000 #hospitals nationwide. With 20 hospitals earning the Honor Roll distinction, the report compared hospitals in 15 specialties and 20 procedures and conditions. Of these, only 160 earned the "Best Hospitals" ranking, signifying excellence in clinical outcomes, nursing care, and patient safety practices. Learn more here: https://ow.ly/k9Tx50SCj0a

In an interview at #SPD2024, Kelly Harris, APRN, of Cincinnati Children's Hospital Medical Center, discusses using mobile care units to deliver #dermatology care & education to underserved communities and how health systems can implement them. Watch here: https://ow.ly/iqzQ50SCiPy

New Peer Exchange Series from AJMC! Join experts as they dive deep into biosimilars, discussing ways to improve adoption and utilization and the impact biosimilars may have in reducing health care costs. Watch the series here: https://bit.ly/3zKjmDW #Biosimilars #Biologics

Get comprehensive coverage of the latest in managed care news, from research to policy updates, event information, and more with The American Journal of Managed Care® (AJMC®). Subscribe to our complimentary e-newsletter today! https://lnkd.in/e3GXHxxC #ManagedCare #AJMC

At this year's Society for Pediatric Dermatology Annual Meeting, a session focused on numerous ways that ChatGPT and other generative AI systems can help dermatologists conduct their practices. “So, can ChatGPT do my job? Not completely. But if you learn to use AI, it may help you do your job even better,” said presenter Albert C. Yan, MD, FAAP, FAAD, a pediatric dermatologist at the Children's Hospital of Philadelphia. Read more! #SPD2024 #PediatricDermatology #ChatGPT #DermatologyInnovation #AI #HealthCareTech

A comprehensive analysis of research spanning from 1990 to 2023 has demonstrated a steady increase in literature focused on macrophages and pulmonary fibrosis, with the United States and China leading in collaborative efforts. Key Findings: Total Publications: Between January 1990 and July 2023, there were 3,479 publications on macrophages and pulmonary fibrosis, averaging about 102 papers per year. Growth Over Time: The number of publications increased steadily from 57 to 117 annually before 2017 and surged to over 200 publications per year starting in 2020. Notable peaks were observed in 1995 and 2022, reflecting significant research activity during these years. Learn more! #PulmonaryFibrosis #MacrophageResearch #MedicalResearch

Meet the chair! Marc Bonaca, MD, MPH, FAHA, FACC, will lead the value-based care event Population Health Lipid Risk Management on August 13 in Aurora, Colorado. Don’t miss the opportunity to gain valuable insight with lipid management! Register here: https://bit.ly/3VW1A81 #ValueBasedCare #PopulationHealth

Selecting the right idiopathic pulmonary fibrosis (IPF) treatment for your patients requires certain considerations. Tune in as Justin Oldham, MD, MS, covers key characteristics of patients presenting with IPF and the challenges often present with the current antifibrotic therapies. Watch the #AJMCInsights episode here: https://bit.ly/3W3bZ33. #IPF

The Society for Pediatric Dermatology (SPD) Annual Meeting, taking place in Toronto, Ontario, Canada, from July 11 to July 15 will feature numerous speakers, sessions, and discussions surrounding the care of dermatology in children, from newborns through adolescents. Be sure to follow along with us as we bring you all the new and late-breaking content from #SPD2024!